Domestic Funds Stay Defensive While Increasing Exposure to NBFCs and Asset Management Stocks

Domestic fund managers largely maintained a cautious and defensive approach towards equity markets during April amid concerns over geopolitical tensions in West Asia and the possibility of higher crude oil prices impacting market sentiment.

At the same time, mutual funds selectively increased exposure to segments within financial services where earnings visibility and long term growth prospects remained relatively stable, as per The Economic Times report.

Defensive Positioning Continues Amid Global Uncertainty

Fund managers continued to favour relatively defensive sectors as investors tracked developments in global energy markets and geopolitical tensions in West Asia. Concerns over elevated oil prices and their potential impact on inflation and corporate earnings contributed to a measured investment strategy across equity portfolios.

This cautious positioning reflected efforts to balance portfolio risk while maintaining exposure to sectors with comparatively stable growth visibility.

Pharmaceutical Stocks Witness Fresh Buying Interest

Apart from financial services, pharmaceutical companies also attracted increased participation from domestic equity schemes, driven partly by product-specific opportunities emerging within the sector.

Investors are closely monitoring the anticipated patent expiry of semaglutide, a widely used weight management drug, which is being viewed as a potential long-term opportunity for Indian pharmaceutical manufacturers.

Read More: Best Balanced Advantage Mutual Funds for May 2026 Based on 5-Year CAGR: HDFC Balanced Advantage Fund, Baroda BNP Paribas Balanced Advantage Fund and More.

Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi.

Conclusion

Domestic mutual funds maintained a cautious investment approach in April by retaining exposure to defensive sectors while selectively increasing allocations to financial services and pharmaceutical companies. The portfolio adjustments indicate a preference for businesses with visible growth potential amid ongoing global and macroeconomic uncertainties.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Mutual fund investments in the securities market are subject to market risks, read all the related documents carefully before investing.